Adamis Pharmaceuticals (ADMP) Open to New Partnerships for EpiPen Alternative; Targets New NDA Submission by Year End - Bloomberg
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Adamis Pharmaceuticals (NASDAQ: ADMP) Open to New Partnerships for EpiPen Alternative; Targets New NDA Submission by Year End - Bloomberg
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DragonWave's (DRWI) Harmony Radio, Hub 800 Products Selected by Leading Australian Telecom
- Vail Resorts (MTN) Names New Board Member
- DBV Technologies (DBVT) Announces Topline data from Two-Year OLFUS-VIPES Study; No SAEs Reported
Create E-mail Alert Related CategoriesManagement Comments, Momentum Movers
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!